UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 234

Sortiert nach

TDP-43 in amyotrophic lateral sclerosis - is it a prion disease?

European journal of neurology, 2015-05, Vol.22 (5), p.753-761

2015

Link zum Volltext

Verfügbarkeit prüfen

Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology

Brain (London, England : 1878), 2014-06, Vol.137 (Pt 6), p.1733-1740

2014

Link zum Volltext

Verfügbarkeit prüfen

Progression of alpha‐synuclein pathology in multiple system atrophy of the cerebellar type

Neuropathology and applied neurobiology, 2017-06, Vol.43 (4), p.315-329

2017

Link zum Volltext

Verfügbarkeit prüfen

Axonal damage markers in cerebrospinal fluid are increased in ALS

Neurology, 2006-03, Vol.66 (6), p.852

2006

Link zum Volltext

Verfügbarkeit prüfen

Isolated blood-cerebrospinal fluid barrier dysfunction : prevalence and associated diseases

Journal of neurology, 2005-09, Vol.252 (9), p.1067-1073

2005

Link zum Volltext

Verfügbarkeit prüfen

Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis

Multiple sclerosis, 2006-04, Vol.12 (2), p.143-148

2006

Link zum Volltext

Verfügbarkeit prüfen

CSF glial markers correlate with survival in amyotrophic lateral sclerosis

Neurology, 2010-03, Vol.74 (12), p.982

2010

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal fluid proteome profile in multiple sclerosis

Multiple sclerosis, 2007-08, Vol.13 (7), p.840-849

2007

Link zum Volltext

Verfügbarkeit prüfen

Gender-specificities in Alzheimer's disease and mild cognitive impairment

Journal of neurology, 2008, Vol.255 (1), p.117-122

2008

Link zum Volltext

Verfügbarkeit prüfen

Stages of oculomotor dysfunctions confirms the model of axonal spread of pTDP-43 pathology in amyotrophic lateral sclerosis

Clinical neurophysiology, 2016-03, Vol.127 (3), p.e34-e34

2016

Link zum Volltext

Verfügbarkeit prüfen

Detection of chemically induced ecotoxicological effects in rivers of the Nidda catchment (Hessen, Germany) and development of an ecotoxicological, Water Framework Directive–compliant assessment system

Environmental sciences Europe, 2019-01, Vol.31 (1), p.1-22, Article 7

2019

Link zum Volltext

Verfügbarkeit prüfen

CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndrome

Muscle & nerve, 2009-07, Vol.40 (1), p.42-49

2009

Link zum Volltext

Verfügbarkeit prüfen

CSF proteome analysis in clinically isolated syndrome (CIS): Candidate markers for conversion to definite multiple sclerosis

Neuroscience letters, 2009-03, Vol.452 (2), p.214-217

2009

Link zum Volltext

Verfügbarkeit prüfen

Proteome analysis of cerebrospinal fluid in Guillain–Barré syndrome (GBS)

Journal of neuroimmunology, 2007-04, Vol.185 (1), p.190-194

2007

Link zum Volltext

Verfügbarkeit prüfen

Poison in paradise: increase of toxic effects in restored sections of two rivers jeopardizes the success of hydromorphological restoration measures

Environmental sciences Europe, 2019-06, Vol.31 (1), Article 36

2019

Link zum Volltext

Verfügbarkeit prüfen

Small but with big impact? Ecotoxicological effects of a municipal wastewater effluent on a small creek

Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering, 2018-11, Vol.53 (13), p.1-1160

2018

Link zum Volltext

Verfügbarkeit prüfen

A new enzymatic method assessing the impact of wastewater treatment plant effluents on the assimilative capacity of small rivers

Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering, 2019-09, Vol.54 (11), p.1116-1125

2019

Link zum Volltext

Verfügbarkeit prüfen

Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis

Multiple sclerosis, 2005-06, Vol.11 (3), p.261-265

2005

Link zum Volltext

Verfügbarkeit prüfen

Current cerebrospinal fluid diagnostics for pathogen-related diseases

Nervenarzt, 2013-02, Vol.84 (2), p.229-244

2013

Link zum Volltext

Verfügbarkeit prüfen

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)

Journal of neurology, 2014-01, Vol.261 (1), p.1-16

2014

Link zum Volltext

Verfügbarkeit prüfen

An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels

Experimental neurology, 2010-06, Vol.223 (2), p.432-438

2010

Link zum Volltext

Verfügbarkeit prüfen

PO10-TU-22 CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis

Journal of the neurological sciences, 2009, Vol.285, p.S201-S201

2009

Link zum Volltext

Verfügbarkeit prüfen

FP57-FR-05 Prognostic markers in amyotrophic lateral sclerosis (ALS): proteome analysis of cerebrospinal fluid

Journal of the neurological sciences, 2009, Vol.285, p.S148-S148

2009

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal fluid-based diagnostics of CT-negative subarachnoid haemorrhage

Nervenarzt, 2010-08, Vol.81 (8), p.973

2010

Link zum Volltext

Verfügbarkeit prüfen

P03-61 - Characteristic CSF and peripheral blood cytokine levels in neurological and psychiatric patients

European psychiatry, 2010, Vol.25 (S1), p.1183-1183, Article 25-E1171

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 234

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(184)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

TDP-43 in amyotrophic lateral sclerosis - is it a prion disease?

Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology

Progression of alpha‐synuclein pathology in multiple system atrophy of the cerebellar type

Axonal damage markers in cerebrospinal fluid are increased in ALS

Isolated blood-cerebrospinal fluid barrier dysfunction : prevalence and associated diseases

Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis

CSF glial markers correlate with survival in amyotrophic lateral sclerosis

Cerebrospinal fluid proteome profile in multiple sclerosis

Gender-specificities in Alzheimer's disease and mild cognitive impairment

Stages of oculomotor dysfunctions confirms the model of axonal spread of pTDP-43 pathology in amyotrophic lateral sclerosis

Detection of chemically induced ecotoxicological effects in rivers of the Nidda catchment (Hessen, Germany) and development of an ecotoxicological, Water Framework Directive–compliant assessment system

CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndrome

CSF proteome analysis in clinically isolated syndrome (CIS): Candidate markers for conversion to definite multiple sclerosis

Proteome analysis of cerebrospinal fluid in Guillain–Barré syndrome (GBS)

Poison in paradise: increase of toxic effects in restored sections of two rivers jeopardizes the success of hydromorphological restoration measures

Small but with big impact? Ecotoxicological effects of a municipal wastewater effluent on a small creek

A new enzymatic method assessing the impact of wastewater treatment plant effluents on the assimilative capacity of small rivers

Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis

Current cerebrospinal fluid diagnostics for pathogen-related diseases

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)

An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels

PO10-TU-22 CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis

FP57-FR-05 Prognostic markers in amyotrophic lateral sclerosis (ALS): proteome analysis of cerebrospinal fluid

Cerebrospinal fluid-based diagnostics of CT-negative subarachnoid haemorrhage

P03-61 - Characteristic CSF and peripheral blood cytokine levels in neurological and psychiatric patients

Suchergebnisse filtern